ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Tepotinib in Patients with Advanced NSCLC with MET Amplification (METamp)
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2021.10.172
◽
2022
◽
Vol 112
(2)
◽
pp. e6-e7
Author(s):
X. Le
◽
R. O'Hara
◽
L. Paz-Ares
◽
J.P. Van Meerbeeck
◽
S. Viteri Ramirez
◽
...
Keyword(s):
Advanced Nsclc
◽
Met Amplification
Download Full-text
Related Documents
Cited By
References
A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant
Annals of Oncology
◽
10.1093/annonc/mdz063.031
◽
2019
◽
Vol 30
◽
pp. ii51
◽
Cited By ~ 1
Author(s):
J. Qu
◽
L. Liu
◽
J. Heng
◽
C. Zhou
◽
Y. Xiong
◽
...
Keyword(s):
Egfr Mutation
◽
Advanced Nsclc
◽
Treatment Modalities
◽
Met Amplification
◽
Nsclc Patients
◽
Egfr Tki
Download Full-text
P1.01-85 Treatment for Advanced NSCLC with EGFR Mutations and De Novo MET Amplification/Overexpression
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2019.08.800
◽
2019
◽
Vol 14
(10)
◽
pp. S393
Author(s):
H. Wang
◽
W. Li
◽
Q. Deng
◽
J. Kang
◽
H. Chen
◽
...
Keyword(s):
Advanced Nsclc
◽
De Novo
◽
Egfr Mutations
◽
Met Amplification
Download Full-text
Review for "MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti PD‐1 immunotherapy in patients with advanced NSCLC"
10.1002/eji.202048534/v2/review1
◽
2020
◽
Keyword(s):
T Cells
◽
Advanced Nsclc
Download Full-text
Review for "MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti PD‐1 immunotherapy in patients with advanced NSCLC"
10.1002/eji.202048534/v1/review2
◽
2019
◽
Keyword(s):
T Cells
◽
Advanced Nsclc
Download Full-text
Efficacy, safety and predictive biomarker results from a randomized phase II study comparing atezolizumab vs. docetaxel in patients with advanced NSCLC (POPLAR)
Pneumologie
◽
10.1055/s-0036-1572212
◽
2016
◽
Vol 70
(S 01)
◽
Author(s):
A Rittmeyer
◽
A Spira
◽
K Park
◽
J Mazieres
◽
J Vansteenkiste
◽
...
Keyword(s):
Phase Ii
◽
Advanced Nsclc
◽
Phase Ii Study
◽
Predictive Biomarker
◽
Randomized Phase Ii
Download Full-text
Association between immune-related adverse events (irAEs) and atezolizumab efficacy in advanced NSCLC: analyses from the Ph III study OAK
Pneumologie
◽
10.1055/s-0037-1619265
◽
2018
◽
Vol 72
(S 01)
◽
pp. S56-S56
Author(s):
N Reinmuth
◽
K Syrigos
◽
J Mazieres
◽
D Cortinovis
◽
R Dziadziuszko
◽
...
Keyword(s):
Adverse Events
◽
Advanced Nsclc
Download Full-text
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI
Case Medical Research
◽
10.31525/ct1-nct04007835
◽
2019
◽
Author(s):
Keyword(s):
Tyrosine Kinase
◽
Tyrosine Kinase Inhibitor
◽
Advanced Nsclc
◽
Kinase Inhibitor
◽
Acquired Resistance
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
◽
Nsclc Patients
◽
Egfr Tki
Download Full-text
Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC
Case Medical Research
◽
10.31525/ct1-nct04063449
◽
2019
◽
Author(s):
Keyword(s):
Advanced Nsclc
Download Full-text
Clinical Trial Assessing the Effecacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC
Case Medical Research
◽
10.31525/ct1-nct04238169
◽
2020
◽
Author(s):
Keyword(s):
Clinical Trial
◽
Advanced Nsclc
◽
Abscopal Effect
Download Full-text
Split-course Thoracic Radiotherapy Combined With Nab-paclitaxel Plus Nedaplatin for Local Advanced NSCLC With Impaired Baseline Pulmonary Function
Case Medical Research
◽
10.31525/ct1-nct04212052
◽
2019
◽
Author(s):
Keyword(s):
Pulmonary Function
◽
Advanced Nsclc
◽
Thoracic Radiotherapy
◽
Local Advanced
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close